SCM

Superstring Capital Management Portfolio holdings

AUM $102M
1-Year Est. Return 67.26%
This Quarter Est. Return
1 Year Est. Return
+67.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$80.3M
AUM Growth
-$3.57M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$5.1M
2
+$4.74M
3
+$4.68M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$3.88M
5
BCAX
Bicara Therapeutics
BCAX
+$1.76M

Top Sells

1
+$5.6M
2
+$5.44M
3
+$4.97M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$4.81M
5
URGN icon
UroGen Pharma
URGN
+$4.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLTX icon
26
MoonLake Immunotherapeutics
MLTX
$939M
$832K 0.98%
17,623
-14,522
OCUL icon
27
Ocular Therapeutix
OCUL
$2.49B
$826K 0.98%
88,980
+46,683
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$342M
$525K 0.62%
+214,412
WVE icon
29
Wave Life Sciences
WVE
$1.24B
$457K 0.54%
+70,242
BMEA icon
30
Biomea Fusion
BMEA
$71.4M
$450K 0.53%
+250,000
KYTX icon
31
Kyverna Therapeutics
KYTX
$295M
$438K 0.52%
142,542
-48,745
IPSC icon
32
Century Therapeutics
IPSC
$47.3M
$259K 0.31%
462,963
SY
33
So-Young International
SY
$279M
$226K 0.27%
+72,936
RAPT icon
34
RAPT Therapeutics
RAPT
$873M
$208K 0.25%
+26,034
LSB
35
DELISTED
LakeShore Biopharma
LSB
$31.4K 0.04%
30,792
CAPR icon
36
Capricor Therapeutics
CAPR
$304M
– –
-241,192
CPIX icon
37
Cumberland Pharmaceuticals
CPIX
$32.5M
– –
0
CRNX icon
38
Crinetics Pharmaceuticals
CRNX
$4.29B
– –
-43,613
LEGN icon
39
Legend Biotech
LEGN
$4.96B
– –
-160,442
MDGL icon
40
Madrigal Pharmaceuticals
MDGL
$13.2B
– –
-3,815
PCVX icon
41
Vaxcyte
PCVX
$5.96B
– –
-11,264
PFE icon
42
Pfizer
PFE
$144B
– –
-196,164
SDGR icon
43
Schrodinger
SDGR
$1.26B
– –
-14,114
SMMT icon
44
Summit Therapeutics
SMMT
$12.8B
– –
-132,019
SWTX
45
DELISTED
SpringWorks Therapeutics
SWTX
– –
-54,216
TSHA icon
46
Taysha Gene Therapies
TSHA
$1.21B
– –
-755,599
VSTM icon
47
Verastem
VSTM
$779M
– –
-336,363
1
2